Bioengineering of noncoding RNAs for research agents and therapeutics

Pui Yan Ho, Aiming Yu

Research output: Contribution to journalReview article

20 Citations (Scopus)

Abstract

The discovery of functional small noncoding RNAs (ncRNAs), such as microRNAs and small interfering RNAs, in the control of human cellular processes has opened new avenues to develop RNA-based therapies for various diseases including viral infections and cancers. However, studying ncRNA functions and developing RNA-based therapeutics relies on access to large quantities of affordable ncRNA agents. Currently, synthetic RNAs account for the major source of agents for RNA research and development, yet carry artificial modifications on the ribose ring and phosphate backbone in sharp contrast to posttranscriptional modifications present on the nucleobases or unmodified natural RNA molecules produced within cells. Therefore, large efforts have been made in recent years to develop recombinant RNA techniques to cost-effectively produce biological RNA agents that may better capture the structure, function, and safety properties of natural RNAs. In this article, we summarize and compare current in vitro and in vivo methods for the production of RNA agents including chemical synthesis, in vitro transcription, and bioengineering approaches. We highlight the latest recombinant RNA approaches using transfer RNA (tRNA), ribosomal RNA (rRNA), and optimal ncRNA scaffold (OnRS), and discuss the applications of bioengineered ncRNA agents (BERAs) that should facilitate RNA research and development.

Original languageEnglish (US)
Pages (from-to)186-197
Number of pages12
JournalWiley interdisciplinary reviews. RNA
Volume7
Issue number2
DOIs
StatePublished - Mar 1 2016

Fingerprint

Therapeutic Human Experimentation
Bioengineering
Untranslated RNA
RNA
Small Untranslated RNA
Ribose
Biological Factors
Virus Diseases
MicroRNAs
Research
Small Interfering RNA
Phosphates
Safety
Costs and Cost Analysis
Therapeutics
Transcription
Neoplasms
Scaffolds
In Vitro Techniques
Molecules

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology

Cite this

Bioengineering of noncoding RNAs for research agents and therapeutics. / Ho, Pui Yan; Yu, Aiming.

In: Wiley interdisciplinary reviews. RNA, Vol. 7, No. 2, 01.03.2016, p. 186-197.

Research output: Contribution to journalReview article

@article{a318930603784206b9f355e3b6f32035,
title = "Bioengineering of noncoding RNAs for research agents and therapeutics",
abstract = "The discovery of functional small noncoding RNAs (ncRNAs), such as microRNAs and small interfering RNAs, in the control of human cellular processes has opened new avenues to develop RNA-based therapies for various diseases including viral infections and cancers. However, studying ncRNA functions and developing RNA-based therapeutics relies on access to large quantities of affordable ncRNA agents. Currently, synthetic RNAs account for the major source of agents for RNA research and development, yet carry artificial modifications on the ribose ring and phosphate backbone in sharp contrast to posttranscriptional modifications present on the nucleobases or unmodified natural RNA molecules produced within cells. Therefore, large efforts have been made in recent years to develop recombinant RNA techniques to cost-effectively produce biological RNA agents that may better capture the structure, function, and safety properties of natural RNAs. In this article, we summarize and compare current in vitro and in vivo methods for the production of RNA agents including chemical synthesis, in vitro transcription, and bioengineering approaches. We highlight the latest recombinant RNA approaches using transfer RNA (tRNA), ribosomal RNA (rRNA), and optimal ncRNA scaffold (OnRS), and discuss the applications of bioengineered ncRNA agents (BERAs) that should facilitate RNA research and development.",
author = "Ho, {Pui Yan} and Aiming Yu",
year = "2016",
month = "3",
day = "1",
doi = "10.1002/wrna.1324",
language = "English (US)",
volume = "7",
pages = "186--197",
journal = "Wiley interdisciplinary reviews. RNA",
issn = "1757-7004",
publisher = "John Wiley and Sons Inc.",
number = "2",

}

TY - JOUR

T1 - Bioengineering of noncoding RNAs for research agents and therapeutics

AU - Ho, Pui Yan

AU - Yu, Aiming

PY - 2016/3/1

Y1 - 2016/3/1

N2 - The discovery of functional small noncoding RNAs (ncRNAs), such as microRNAs and small interfering RNAs, in the control of human cellular processes has opened new avenues to develop RNA-based therapies for various diseases including viral infections and cancers. However, studying ncRNA functions and developing RNA-based therapeutics relies on access to large quantities of affordable ncRNA agents. Currently, synthetic RNAs account for the major source of agents for RNA research and development, yet carry artificial modifications on the ribose ring and phosphate backbone in sharp contrast to posttranscriptional modifications present on the nucleobases or unmodified natural RNA molecules produced within cells. Therefore, large efforts have been made in recent years to develop recombinant RNA techniques to cost-effectively produce biological RNA agents that may better capture the structure, function, and safety properties of natural RNAs. In this article, we summarize and compare current in vitro and in vivo methods for the production of RNA agents including chemical synthesis, in vitro transcription, and bioengineering approaches. We highlight the latest recombinant RNA approaches using transfer RNA (tRNA), ribosomal RNA (rRNA), and optimal ncRNA scaffold (OnRS), and discuss the applications of bioengineered ncRNA agents (BERAs) that should facilitate RNA research and development.

AB - The discovery of functional small noncoding RNAs (ncRNAs), such as microRNAs and small interfering RNAs, in the control of human cellular processes has opened new avenues to develop RNA-based therapies for various diseases including viral infections and cancers. However, studying ncRNA functions and developing RNA-based therapeutics relies on access to large quantities of affordable ncRNA agents. Currently, synthetic RNAs account for the major source of agents for RNA research and development, yet carry artificial modifications on the ribose ring and phosphate backbone in sharp contrast to posttranscriptional modifications present on the nucleobases or unmodified natural RNA molecules produced within cells. Therefore, large efforts have been made in recent years to develop recombinant RNA techniques to cost-effectively produce biological RNA agents that may better capture the structure, function, and safety properties of natural RNAs. In this article, we summarize and compare current in vitro and in vivo methods for the production of RNA agents including chemical synthesis, in vitro transcription, and bioengineering approaches. We highlight the latest recombinant RNA approaches using transfer RNA (tRNA), ribosomal RNA (rRNA), and optimal ncRNA scaffold (OnRS), and discuss the applications of bioengineered ncRNA agents (BERAs) that should facilitate RNA research and development.

UR - http://www.scopus.com/inward/record.url?scp=84958943246&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84958943246&partnerID=8YFLogxK

U2 - 10.1002/wrna.1324

DO - 10.1002/wrna.1324

M3 - Review article

C2 - 26763749

AN - SCOPUS:84958943246

VL - 7

SP - 186

EP - 197

JO - Wiley interdisciplinary reviews. RNA

JF - Wiley interdisciplinary reviews. RNA

SN - 1757-7004

IS - 2

ER -